7 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Ionis Pharmaceuticals, Inc. | 6 |
| Ionis Pharmaceuticals, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18561434 | COMPOUNDS FOR REDUCING PTBP1 EXPRESSION | Ionis Pharmaceuticals, Inc. | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Nov 16, 2023 |
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | Ionis Pharmaceuticals, Inc. | CHONG, KIMBERLY | 1636 | Non-Final OA | Aug 15, 2023 |
| 18247311 | COMPOUNDS FOR MODULATING CHMP7 | Ionis Pharmaceuticals, Inc. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Mar 30, 2023 |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | Ionis Pharmaceuticals, Inc. | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Final Rejection | Dec 14, 2022 |
| 17522594 | COMPOUNDS AND METHODS FOR REDUCING SNCA EXPRESSION | Ionis Pharmaceuticals, Inc. | MCLEOD, AFRICA MHAIRIE | 1635 | Non-Final OA | Nov 09, 2021 |
| 17416392 | COMPOUNDS AND METHODS FOR REDUCING PMP22 EXPRESSION | Ionis Pharmaceuticals, Inc. | MEYERING, SHABANA SHABBEER | 1635 | Final Rejection | Jun 18, 2021 |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | Ionis Pharmaceuticals, Inc. | ANGELL, JON E | 1637 | Final Rejection | Jun 18, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial